PARIS - US pharmaceutical company Moderna is to make a formal application to European medical authorities to approve its coronavirus vaccine for people aged 12 to 17, chief executive Stephane Bancel told French newspaper Le Journal du Dimanche.
The application will be lodged with European Medicines Agency (EMA) early in June, Bancel said.
EMA had previously announced that it would decide this month on whether to approve the vaccine from BioNTech/Pfizer for young people over 12 years old. The United States has already approved the BioNTech/Pfizer vaccine for use on children in this age group.
Moderna's vaccine is one of four coronavirus vaccines licensed for adult use in the EU.